|View printer-friendly version|
|September 22, 2004 5:17 p.m.|
|Teva Announces Tentative Approval Of Cetirizine Hcl Tablets|
Jerusalem, Israel, September 22, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Cetirizine Hydrochloride Tablets, 5 mg and 10 mg. Final approval is anticipated upon expiration of patent protection on December 25, 2007.